Zhenwei Wen

Zhenwei Wen

Auto-generated profile, based on publicly available information

Zhenwei Wen

West China School of Stomatology, Sichuan University, Chengdu, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Human Mutation
Verified
Journal Article
Open access
TYTongnan Yin
Tongnan Yin
QGQian Guo
Qian Guo
ZWZhenwei Wen
Zhenwei Wen
YGYikun Guo
Yikun Guo
CLChenwen Li
Chenwen Li
ZQZhongyu Qu
Zhongyu Qu
Head and neck squamous cell carcinoma (HNSCC) ranks second among men and sixth globally, with a notable increase in HPV‐associated cases. However, the molecular underpinnings and immune landscape of HPV+ HNSCC remain incompletely understood. In this study, we first retrieved and harmonized single‐cell RNA sequencing (RNA‐Seq), bulk RNA‐Seq, and spatial transcriptomic profiles from public repositories. We then applied high‐dimensional weighted gene coexpression network analysis (hdWGCNA) and gene nonnegative matrix factorization (GeneNMF) to dissect HPV+ epithelial subpopulations, their extracellular matrix (ECM)–interacting ligand programs, and CXCL/complement immune circuits. Furthermore, we mapped the spatial niches of malignant and immune cells and constructed a consensus prognostic index using 101 machine learning algorithms. Our findings revealed transcriptionally distinct HPV+ epithelial clusters that activate viral oncogenesis, inflammatory pathways, and ECM‐sensing pathways. These cells communicate with stromal and immune compartments via CXCL axes and complement cascades, yet they are spatially segregated from lymphocytes. A high‐risk signature, identified as HPV‐related risk genes including TRMT112, stratified the TCGA‐HNSC and GSE65858 cohorts into patients with markedly worse 1‐, 2‐, and 3‐year survival rates (ROC–AUC 0.934, 0.968, and 0.973) and poor responses to immunotherapy. Notably, TRMT112 expression inversely correlated with cytotoxic T‐cell infiltration, mechanistically linking it to the formation of “cold” tumors. Our integrative analysis defines HPV‐driven epithelial subpopulations whose TRMT112‐enriched, immune‐excluded microenvironment contributes to therapeutic resistance, thus providing robust prognostic biomarkers and actionable targets for precision immunotherapy in HPV+ HNSCC.

25 September 2025 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
HXHongye Xu
Hongye Xu
LWLijun Wang
Lijun Wang
LXLi Xu
Li Xu
XZXiaoxi Zhang
Xiaoxi Zhang
HMHongyu Ma
Hongyu Ma
PYPengfei Yang
Pengfei Yang
The association between serum bilirubin levels and clinical outcomes in acute ischemic stroke (AIS) patients undergoing mechanical thrombectomy (MT) remains elusive, warranting further investigation. This retrospective cohort study encompassed 787 AIS patients who underwent MT between January 2018 and December 2022. Baseline serum levels of direct bilirubin (DBIL), indirect bilirubin (IBIL), and total bilirubin (TBIL) were documented. Adverse clinical outcomes comprised any intracranial hemorrhage (ICH) within 72 h, symptomatic intracranial hemorrhage, stroke-associated pneumonia (SAP), early neurological deterioration, 3-month poor functional outcome, and 3-month mortality. The findings revealed that DBIL and TBIL levels exhibited positive correlations with the incidence of SAP, ICH, and 3-month poor functional outcome. IBIL levels demonstrated a positive association with ICH occurrence. Notably, DBIL tends to exhibite superior predictive value for adverse outcomes compared to IBIL and TBIL. In conclusion, baseline serum bilirubin could as a potential biomarker for adverse clinical outcomes in AIS patients undergoing MT, pending further validation.